Sexual behaviours and risk with women in MSM in sub-Saharan Africa
Marion Fiorentino,Nathan Yanwou,Robinson Gravier-Dumonceau Mazelier,August Eubanks,Perrine Roux,Christian Laurent,Bruno Spire
DOI: https://doi.org/10.1097/qad.0000000000003787
IF: 4.632
2024-02-03
AIDS
Abstract:In 2022, sub-Saharan Africa (SSA) – which comprises Central, East, Southern, and West Africa – had 25.6 million people with HIV (PWH), accounting for 66% of all PWH worldwide [1] . In the rest of the world, HIV epidemics are mostly concentrated in key populations (i.e. sex workers, people who inject drugs, MSM, and transgender women), with prevalence generally below 1% in the general population. In contrast, in East and Southern Africa, the HIV epidemic is considered generalized, with prevalence in the general population ranging from 5 to 30%, with key populations accounting for only 14% of new infections in 2020. In West and Central Africa, the HIV epidemic is generally considered mixed with HIV prevalence in the general population ranging from 1 to 5%, while key populations accounted for 45% of new infections in 2020 [1–4] . These figures highlight the need to investigate the risk of HIV bridging from key populations to the general population in SSA.
immunology,infectious diseases,virology